Toward a positive psychology of psychoactive drug use
This paper (2021) makes a case for broadening our conceptualization of substance use in order to develop more effective drug policy and education. It is argued that we need to move beyond our current framing of substance use as a pathological issue and that research on recreational drug use would be beneficial. Incorporating perspectives on positive drug use would enhance prevention and harm reduction strategies.
Authors
- Arnaud, K. O. S.
Published
Abstract
This article advances the proposition that contemporary perspectives on psychoactive drug use are epistemologically limited and that a broadened conceptualization of substance use would aid the development of more effective drug policy and education. It contends that psychoactive substance use cannot be accounted for from an exclusively pathological frame of reference and that by neglecting positive drug instrumentalization, opportunities to advance public health, safety, and well-being are being overlooked. Using the field of positive psychology as a point of comparison, this article thus argues for greater acknowledgment of, and research on, beneficial recreational substance use. The adaptive function of psychoactive drug use and the limitations of conceptual discourse which fails to distinguish between deleterious and salubrious use are first discussed. This is followed by an overview of the cartography of psychoactive drug use and consideration of biopsychosocial parameters germane to positive drug instrumentalization. The classic psychedelics are highlighted due to their psychopharmacological properties and tendency to evoke self-transcendent states. Limitations of regulatory and educational approaches grounded exclusively in the pathological paradigm are broached, with a discussion of how incorporating perspectives on positive drug use would complement extant models of prevention and harm reduction. Areas for future research are considered.
Research Summary of 'Toward a positive psychology of psychoactive drug use'
Introduction
Over recent decades, scholarship and public policy have emphasised the harms of psychoactive substances—substance use disorders, substance-induced disorders, and associated physical, psychological, and social consequences. St and colleagues argue that this dominant medico-legal and clinical discourse has become epistemologically narrow by largely treating drug use as inherently pathological. The introduction frames this imbalance as analogous to the historical focus of clinical psychology on psychopathology, which prompted the rise of positive psychology to study wellness and flourishing alongside disorder. This paper sets out to broaden the conceptual landscape of substance use by foregrounding the positive end of the drug-use spectrum. Rather than denying the reality of addiction and harm, St proposes that complementary research on beneficial, controlled, or instrumental drug use could improve drug policy, education, prevention, and public health. The article therefore offers a theoretical comparison with positive psychology, discusses adaptive and evolutionary accounts of psychoactive use, outlines a spectrum of outcomes, examines biopsychosocial parameters that predict beneficial versus harmful use, highlights classic psychedelics as particularly relevant, and considers implications for regulation, education, and future research.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Topics
- APA Citation
St. Arnaud, K. O. (2023). Toward a positive psychology of psychoactive drug use. Drugs: Education, Prevention and Policy, 30(1), 81-94. https://doi.org/10.1080/09687637.2021.2002816
References (28)
Papers cited by this study that are also in Blossom
Bogenschutz, M. P., Johnson, M. W. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)
Canal, C. E., Murnane, K. S. · Journal of Psychopharmacology (2016)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Substance Use (2010)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Cummins, C., Lyke, J. · Journal of Psychoactive Drugs (2013)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Haden, M., Emerson, B., Tupper, K. W. · Journal of Psychoactive Drugs (2016)
Halberstadt, A. L. · Behavioural Brain Research (2014)
Hartogsohn, I. · Drug Science Policy and Law (2017)
Show all 28 referencesShow fewer
Hendricks, P. S. · International Review of Psychiatry (2018)
Hendricks, P. S., Clark, B., Johnson, M. W. et al. · Journal of Psychopharmacology (2014)
Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)
Johnson, M. W., Griffiths, R. R. · Neurotherapeutics (2017)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Lewis, S. E. · AnthroSource (2008)
Schumann, G., Müller, C. P. · Behavioral and Brain Sciences (2011)
Neitzke-Spruill, L., Glasser, C. · Journal of Psychoactive Drugs (2018)
Nichols, D. E. · Pharmacological Reviews (2016)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)
Passie, T., Halpern, J. H., Stichtenoth, D. O. et al. · CNS Neuroscience and Therapeutics (2008)
Passie, T., Seifert, J., Schneider, U. et al. · Addiction Biology (2002)
Strassman, R. J. · Journal of Nervous and Mental Disease (1984)
Tylš, F., Páleníček, T., Horacek, J. · European Neuropsychopharmacology (2013)
Walsh, Z., Hendricks, P. S., Smith, S. et al. · Journal of Psychopharmacology (2016)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.